Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT04921943

Hypertonic Saline for MAC

Led by Oregon Health and Science University · Updated on 2025-08-15

50

Participants Needed

3

Research Sites

241 weeks

Total Duration

On this page

Sponsors

O

Oregon Health and Science University

Lead Sponsor

N

NTM Info & Research, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.

CONDITIONS

Official Title

Hypertonic Saline for MAC

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 2 positive MAC sputum cultures in the last 12 months with at least one acid-fast bacilli positive sputum obtained within 12 weeks before randomization
  • Meet American Thoracic Society/Infectious Disease Society of America 2007 pulmonary clinical disease criteria
  • Age 18 years or older
  • Diagnosis of bronchiectasis and/or bronchiectatic findings on chest CT report
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide consent or comply with the study protocol
  • Cavitary nontuberculous mycobacterial disease
  • Use of bedaquiline or any ATS/IDSA recommended MAC treatment drugs (macrolide, ethambutol, rifampin) within the past 6 months
  • Diagnosis of HIV infection
  • Diagnosis of cystic fibrosis
  • Active pulmonary tuberculosis, fungal, or nocardial infection requiring treatment at screening
  • Use of chronic systemic corticosteroids at doses of 15 mg/day or more for over 3 months
  • Prior lung or other solid organ transplant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

NYU Langone Health

New York, New York, United States, 10016

Active, Not Recruiting

2

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

3

University Health Network

Toronto, Ontario, Canada, ON M5G

Actively Recruiting

Loading map...

Research Team

D

Daniel Bouchat

CONTACT

A

Alyssa Schroeder

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here